Your browser doesn't support javascript.
loading
HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma.
Shen, Chen; Li, Mei; Duan, Yujuan; Jiang, Xin; Hou, Xiaoming; Xue, Fulai; Zhang, Yinan; Luo, Yao.
Afiliación
  • Shen C; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li M; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Duan Y; School of Chemical Science and Engineering, Tongji University, Shanghai, China.
  • Jiang X; School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Hou X; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xue F; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Luo Y; School of Chemical Science and Engineering, Tongji University, Shanghai, China.
Front Immunol ; 14: 1170207, 2023.
Article en En | MEDLINE | ID: mdl-37304265

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China